Your browser is no longer supported. Please, upgrade your browser.
Settings
OBLN Obalon Therapeutics, Inc. daily Stock Chart
OBLN [NASD]
Obalon Therapeutics, Inc.
Index- P/E- EPS (ttm)-13.44 Insider Own5.10% Shs Outstand5.69M Perf Week17.39%
Market Cap12.29M Forward P/E- EPS next Y-8.33 Insider Trans- Shs Float5.32M Perf Month-13.94%
Income-30.60M PEG- EPS next Q-2.15 Inst Own21.00% Short Float0.75% Perf Quarter-68.24%
Sales7.20M P/S1.71 EPS this Y5.60% Inst Trans-12.33% Short Ratio0.08 Perf Half Y-87.87%
Book/sh3.12 P/B0.69 EPS next Y9.60% ROA-102.90% Target Price19.50 Perf Year-93.55%
Cash/sh2.37 P/C0.91 EPS next 5Y- ROE-253.80% 52W Range1.64 - 34.50 Perf YTD-89.57%
Dividend- P/FCF- EPS past 5Y- ROI-160.70% 52W High-93.74% Beta-
Dividend %- Quick Ratio1.50 Sales past 5Y- Gross Margin32.70% 52W Low31.33% ATR0.24
Employees100 Current Ratio1.70 Sales Q/Q-85.20% Oper. Margin- RSI (14)41.32 Volatility16.15% 11.35%
OptionableYes Debt/Eq0.60 EPS Q/Q56.00% Profit Margin- Rel Volume1.53 Prev Close2.21
ShortableYes LT Debt/Eq0.00 EarningsOct 23 BMO Payout- Avg Volume496.23K Price2.16
Recom1.70 SMA202.48% SMA50-45.92% SMA200-80.41% Volume760,673 Change-2.26%
Feb-25-19Upgrade Stifel Hold → Buy $2.50 → $3
Aug-03-18Reiterated Stifel Hold $3 → $2
Sep-03-19 09:00AM  Obalon Engages Helmuth T. Billy, MD as Medical Director for its First Company-Owned Weight Loss Treatment Center GlobeNewswire
Aug-05-19 09:00AM  Obalon Therapeutics to Present at the Canaccord Genuity 39th Annual Growth Conference GlobeNewswire
Aug-02-19 08:48AM  Obalon Therapeutics Inc. Announces Pricing of $15,000,000 Public Offering GlobeNewswire -33.20%
Jul-26-19 04:00PM  Edited Transcript of OBLN earnings conference call or presentation 24-Jul-19 12:30pm GMT Thomson Reuters StreetEvents +21.72%
Jul-24-19 09:05AM  OBALON THERPTCS (OBLN) Reports Q2 Loss, Misses Revenue Estimates Zacks -40.41%
08:53AM  Obalon Announces Reverse Stock Split Effective Today GlobeNewswire
07:45AM  Obalon Announces Second Quarter 2019 Financial Results GlobeNewswire
Jul-23-19 08:30AM  Obalon Enters Into Commercial Lease for its First Company-Owned Retail Weight Loss Center GlobeNewswire +31.51%
Jul-22-19 09:00AM  Obalon Schedules Second Quarter 2019 Financial Results Conference Call for July 24, 2019 at 8:30 a.m. Eastern Time GlobeNewswire +20.66%
Jul-16-19 08:30AM  Obalon Obtains Two New U.S. Patents Covering Its Proprietary Intragastric Balloon System GlobeNewswire
Jul-10-19 08:30AM  Obalon Strengthens Balance Sheet By Raising Additional Capital And Reducing Debt GlobeNewswire +11.57%
Jun-24-19 08:30AM  Bariatric Medical Institute of Texas Presents Favorable Study Results for Obalon Balloon Administration Using Navigation Device and Touch Dispenser GlobeNewswire +26.34%
Jun-10-19 08:30AM  Obalon Appoints Bob MacDonald as Chief Retail Officer GlobeNewswire
Jun-04-19 11:42AM  Obalon Clinches First US Patent For Obesity Treatment Placement System Benzinga
08:30AM  Obalon Announces Issuance of First U.S. Patent Covering Its Proprietary Navigation System GlobeNewswire
Jun-03-19 08:57AM  Hottest Wall Street Stories: What's Up, What's Down Zacks
May-24-19 05:50PM  OBALON THERPTCS (OBLN) Stock Sinks As Market Gains: What You Should Know Zacks
12:50PM  A Look At Benzinga Pro's Most-Searched Tickers For May 24 Benzinga
May-23-19 10:00AM  Obalon Management Takes Advantage Of 200% Rally, Announces $3M Offering Benzinga -47.69%
08:30AM  Obalon Therapeutics, Inc. Prices $3,000,000 Registered Direct Offering GlobeNewswire
May-21-19 04:01PM  Expanded Clinical Data Set for the Obalon Balloon System Presented at DDW 2019 GlobeNewswire
May-17-19 05:50PM  OBALON THERPTCS (OBLN) Dips More Than Broader Markets: What You Should Know Zacks
04:01PM  Obalon Announces Receipt of Delisting Notification Letters from Nasdaq GlobeNewswire
May-02-19 10:33AM  Will OBALON THERPTCS (OBLN) Report Negative Q1 Earnings? What You Should Know Zacks
Apr-11-19 08:00AM  Obalon Engages Cowen to Explore Financial and Strategic Alternatives GlobeNewswire -7.43%
Apr-03-19 08:30AM  Obalon Announces Restructuring to Streamline Operations & Cash Use GlobeNewswire -61.87%
Mar-14-19 09:00AM  Obalon Announces Upcoming Conference Presentations GlobeNewswire
Feb-27-19 09:00AM  Obalon Announces First Commercial Use of Navigation and Touch Products for Obalon Balloon Administration GlobeNewswire -6.01%
Feb-26-19 02:15AM  Edited Transcript of OBLN earnings conference call or presentation 22-Feb-19 1:30pm GMT Thomson Reuters StreetEvents -6.54%
Feb-22-19 10:05AM  OBALON THERPTCS (OBLN) Reports Q4 Loss, Lags Revenue Estimates Zacks -10.09%
08:25AM  Obalon Announces First Commercial Shipment of its Navigation Balloon Placement System with Touch Inflation Dispenser GlobeNewswire
08:00AM  Obalon Announces Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
06:30AM  Obalon Therapeutics, Inc. to Host Earnings Call ACCESSWIRE
Feb-21-19 09:38AM  How Many Insiders Bought Obalon Therapeutics, Inc. (NASDAQ:OBLN) Shares? Simply Wall St.
Feb-15-19 09:00AM  Obalon Schedules Fourth Quarter and Year End 2018 Financial Results Conference Call for February 22, 2019 at 8:30 a.m. Eastern Time GlobeNewswire
Jan-03-19 08:15AM  Obalon Announces Promotion of Amy VandenBerg to Chief Clinical & Regulatory Affairs Officer GlobeNewswire -15.65%
Jan-02-19 09:00AM  Obalon to Host Call to Provide Update on Commercial Strategy Post FDA Approval of the Obalon Navigation System GlobeNewswire +11.11%
08:45AM  Obalon Announces Promotion of Kelly Huang, Ph.D. To Chief Executive Officer GlobeNewswire
Dec-28-18 10:16AM  Small Cap Biotech Stocks on the Rise ACCESSWIRE -13.79%
07:29AM  The Daily Biotech Pulse: Opko Settles With SEC, Obalon Inks Financing Deals, Harpoon Files For IPO Benzinga
Dec-27-18 05:53PM  Obalon Therapeutics, Inc. Announces Two Agreements To Provide Up To $30 Million of Capital GlobeNewswire
Dec-21-18 10:45AM  These 4 Pharma Stocks Could Test December Highs ACCESSWIRE +61.59%
09:00AM  Obalon Announces FDA Approval of Obalon Navigation System GlobeNewswire
Dec-20-18 11:07AM  What You Must Know About Obalon Therapeutics, Inc.s (NASDAQ:OBLN) Financial Strength Simply Wall St.
Dec-19-18 12:38PM  Edited Transcript of OBLN earnings conference call or presentation 2-Aug-18 12:30pm GMT Thomson Reuters StreetEvents
Dec-13-18 09:21AM  5 Battered Stocks That Could Be Big Winners in 2019 Zacks
Nov-15-18 09:15AM  Key Weight Loss and Safety Data Presented for the Obalon Swallowable Gas-Filled Balloon System at the 35th ASMBS Annual Meeting at Obesity Week 2018 GlobeNewswire
Nov-13-18 08:40AM  Recent Analysis Shows Howard Hughes, Obalon Therapeutics, SMTC, Eastman Kodak, Communications, and Arcadia Biosciences Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Nov-12-18 03:26PM  Edited Transcript of OBLN earnings conference call or presentation 2-Nov-18 12:30pm GMT Thomson Reuters StreetEvents
Nov-07-18 09:15AM  Obalon Balloon System Data to be Featured in Presentation During 35th ASMBS Annual Meeting at Obesity Week 2018 GlobeNewswire
Nov-06-18 09:15AM  Obalon Announces Upcoming Conference Presentations GlobeNewswire
Nov-02-18 09:25AM  OBALON THERPTCS (OBLN) Reports Q3 Loss, Tops Revenue Estimates Zacks -8.84%
08:01AM  Obalon Announces Third Quarter 2018 Financial Results GlobeNewswire
Oct-29-18 11:07AM  Will Obalon's (OBLN) Q3 Earnings Reflect Growth in U.S.? Zacks
Oct-26-18 10:30AM  OBALON THERPTCS (OBLN) Q3 Earnings Preview: What to Expect Zacks
Oct-23-18 09:04AM  Obalon Schedules Third Quarter 2018 Financial Results Conference Call for November 2, 2018 at 8:30 a.m. Eastern Time GlobeNewswire
Oct-09-18 09:02AM  Daina Schmidt Joins Obalon Therapeutics As Vice President, Marketing GlobeNewswire +10.90%
Sep-26-18 09:02AM  FDA Grants PMA-S Approval for Obalon Touch Inflation System GlobeNewswire
Sep-12-18 02:00PM  What Kind Of Shareholders Own Obalon Therapeutics Inc (NASDAQ:OBLN)? Simply Wall St.
Aug-29-18 09:01AM  Obalon to Host Corporate Strategy Update Call with Investors and Analysts on September 10, 2018 GlobeNewswire
Aug-27-18 09:02AM  Obalon Therapeutics Announces Closing of $10 Million Private Placement GlobeNewswire +5.38%
Aug-24-18 08:00AM  Today's Research Reports on Stocks to Watch: Obalon Therapeutics and Viking Therapeutics ACCESSWIRE
Aug-23-18 12:50PM  These Biotech Stocks Are Moving Higher in August ACCESSWIRE +52.00%
09:02AM  Obalon Therapeutics to Raise $10 Million in Private Placement GlobeNewswire
Aug-07-18 09:02AM  Obalon Announces Upcoming Conference Presentation GlobeNewswire
Aug-02-18 08:00AM  Obalon Announces Second Quarter 2018 Financial Results GlobeNewswire
07:55AM  Obalon Promotes Kelly Huang, Ph.D. to President GlobeNewswire
Jul-24-18 10:02AM  Obalon Schedules Second Quarter 2018 Financial Results Conference Call for August 2, 2018 at 8:30 a.m. Eastern Time GlobeNewswire
Jun-06-18 09:01AM  FDA Letter to Health Care Providers Related to Potential Risks, Including Death, with Liquid-Filled Intragastric Balloons for Weight Loss NOT Related to The Obalon Gas-Filled Balloon GlobeNewswire
Jun-05-18 09:10AM  Lawsuit for Investors in shares of Obalon Therapeutics Inc (NASDAQ:OBLN) announced by Shareholders Foundation GlobeNewswire
09:01AM  Obalon Announces Upcoming Conference Presentation GlobeNewswire
May-17-18 04:31PM  Obalon Announces Upcoming Conference Presentation GlobeNewswire
May-10-18 04:01PM  Obalon Announces First Quarter 2018 Financial Results GlobeNewswire
May-07-18 04:06PM  Todd Wood joins Obalon Therapeutics, Inc. as Vice President Global Sales GlobeNewswire
May-04-18 10:01AM  Obalon Schedules First Quarter 2018 Financial Results Conference Call for May 10, 2018 at 5:00 p.m. Eastern Time GlobeNewswire
Apr-16-18 11:10AM  DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Obalon Therapeutics, Inc. and Reminds Investors With Losses in Excess of $50,000 to Contact The Firm ACCESSWIRE
Apr-13-18 11:35AM  DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Obalon Therapeutics, Inc. and Reminds Investors With Losses in Excess of $50,000 to Contact The Firm ACCESSWIRE
Apr-12-18 09:01PM  April 16th Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Obalon Therapeutics, Inc. (OBLN) Business Wire
01:00PM  4-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Obalon Therapeutics, Inc. and Reminds Investors With Losses in Excess of $50,000 to Contact The Firm ACCESSWIRE
11:24AM  Scott+Scott, Attorneys at Law, LLP Reminds Investors of Securities Class Action Against Obalon Therapeutics, Inc. (OBLN) and April 16 Lead Plaintiff Deadline PR Newswire
Apr-11-18 07:32PM  OBLN INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Obalon Therapeutics, Inc. Investors Business Wire
12:25PM  APRIL 16 DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Obalon Therapeutics, Inc. and Reminds Investors With Losses in Excess of $50,000 to Contact The Firm ACCESSWIRE
12:00PM  April 16 DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Obalon Therapeutics, Inc. and Reminds Investors With Losses in Excess of $50,000 to Contact The Firm ACCESSWIRE
10:00AM  DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Obalon Therapeutics, Inc. (OBLN) & Lead Plaintiff Deadline - April 16, 2018 GlobeNewswire
Apr-10-18 07:22PM  Glancy Prongay & Murray LLP Reminds Investors of the April 16, 2018 Deadline in the Class Action Lawsuit Against Obalon Therapeutics, Inc. (OBLN) Business Wire
Apr-09-18 04:21PM  Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Obalon Therapeutics, Inc. (OBLN) and Encourages Investors to Contact the Firm Before April 16th Business Wire
Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people who are obese and overweight. The company offers the Obalon balloon system designed to provide weight loss in obese patients. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.